logo
Rate of initial denials of medical insurance claims continued to rise in 2024, Kodiak Solutions' proprietary data show

Rate of initial denials of medical insurance claims continued to rise in 2024, Kodiak Solutions' proprietary data show

Business Wire21-05-2025
INDIANAPOLIS--(BUSINESS WIRE)--Hospitals, health systems and medical practices faced insurance claims practices that slowed payments for needed medical care in 2024 compared with 2023, new Kodiak Solutions revenue cycle data show.
'Payors appear to be using initial denials to slow payments, even though they ultimately pay approximately 90% of claims, a trend we have been tracking." -- Matt Szaflarski, Kodiak's vice president, revenue cycle intelligence
Share
Medical providers also collected about $3 less for every $100 dollars that insured patients owed on their portion of their medical bills, the data also show. The data are from more than 2,100 hospitals and 300,000 physicians that use the Kodiak Revenue Cycle Analytics platform to manage their net revenue and monitor their revenue cycle performance.
The initial denial rate on claims in 2024 increased 2.4% to 11.81% of claims in 2024. The rate climbed even as medical providers have managed to cut the rate of initial denials related to authorization issues by 7.7%. Denials related to questions of medical necessity and requests for more information (RFI) more than made up the difference, with the rates for both categories increasing by 5% and 5.4%, respectively. Kodiak Solutions first highlighted the increase in RFI initial denials in August 2024.
'Payors appear to be using initial denials to slow payments, even though they ultimately pay approximately 90% of claims, a trend we have been tracking,' said Matt Szaflarski, Kodiak's vice president, revenue cycle intelligence. 'Even if the claims are ultimately paid, initial denials still cost hospitals, health systems and medical providers a lot of resources to overturn, and they also slow cash flow.'
Kodiak Solutions data show that true accounts receivable (AR) days increased 5.2% year-over-year.
Provider organizations collected 34.46% of amounts owed by insured patients, down 8.3% from 2023's self-pay rate for insured patients of 37.58%.
Lessons from revenue cycle leaders
Conversations with leaders of health systems that were recognized in Kodiak's annual Revenue Cycle Performance Awards yielded tips for improving performance that are detailed in the May 2025 Kodiak RCA Benchmarking Analysis. These high-performing revenue cycle teams shared three attributes:
A close working relationship with clinical leaders
Accountability for team members to revenue cycle performance metrics
Strong relationships with payors.
To learn more about the data and insights Kodiak Solutions can provide to benchmark your revenue cycle performance, contact Szaflarski at (463) 270-8123.
About Kodiak Solutions
Kodiak Solutions is a leading technology and tech-enabled services company that simplifies complex business problems for healthcare provider organizations. For nearly two decades as a part of Crowe LLP, Kodiak created and developed our proprietary net revenue reporting solution, Revenue Cycle Analytics. Kodiak also provides a broad suite of software and services in support of CFOs looking for solutions in financial reporting, reimbursement, revenue cycle, risk and compliance, and unclaimed property. Kodiak's 450 employees engage with more than 2,100 hospitals and 300,000 practice-based physicians, across all 50 states, and serve as the unclaimed property outsourcing provider of choice for more than 2,000 companies. To learn more, visit our website.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SCENTMATIC's AI "KAORIUM" Debuts at THAMEEN Fragrance Launch in London's Selfridges
SCENTMATIC's AI "KAORIUM" Debuts at THAMEEN Fragrance Launch in London's Selfridges

Business Wire

timean hour ago

  • Business Wire

SCENTMATIC's AI "KAORIUM" Debuts at THAMEEN Fragrance Launch in London's Selfridges

LONDON--(BUSINESS WIRE)--SCENTMATIC Inc., a leader in scent digitalization, introduced its AI-powered scent-to-language system, KAORIUM, at the THAMEEN Fragrance new product launch event. This pivotal event took place from June 5 to 11, 2025, at Selfridges department store in London, UK. Global Expansion: KAORIUM Establishes UK Presence Europe leads the global fragrance market, with the UK projected to reach US$2.82 billion by 2033. Recognizing this, SCENTMATIC is rapidly expanding its international footprint. In May 2024, SCENTMATIC established its overseas subsidiary, KAORIUM, in London, appointing industry expert Ben Yanoushek as CEO. Official UK operations commenced on February 1, 2025, with the launch of its dedicated website: KAORIUM Trialed at "Florentine Diamond" Launch Event The "Florentine Diamond" launch event for luxury brand THAMEEN Fragrance served as the initial trial for KAORIUM. Held in a prestigious section of Selfridges' beauty hall, the event attracted many visitors. On the opening day, a special breakfast event for industry professionals and influencers at Selfridges' "Brasserie of Light" allowed guests to experience KAORIUM firsthand through individual sessions. SCENTMATIC remains dedicated to showcasing KAORIUM's innovative ability to blend scent and language, enhancing sensory experiences both domestically and internationally. About THAMEEN Fragrance THAMEEN, a UK-based niche fragrance brand, translates to "precious" in Arabic. Inspired by rare jewels, it crafts exquisite, long-lasting Extrait de Parfums using carefully selected, high-quality ingredients. What is "KAORIUM"? KAORIUM is SCENTMATIC's AI system that mutually translates between scent and language. It visualizes elusive scent impressions with words and identifies scents linked to specific words. This unique experience activates both brain hemispheres, unlocking new sensitivities. KAORIUM's potential spans fragrance, education, dining, and purchasing, creating diverse business opportunities. SCENTMATIC Inc. Established in 2019, SCENTMATIC is a business design collective focused on "digitalizing olfaction." Through scent and language, it aims to evolve human sensibility and innovate various industries by adding emotional value to experiences. Representative: Toshiharu Kurisu Representative Director Location: 3F, 4-22-7 Ebisu, Shibuya-ku, Tokyo 150-0013, Japan URL:

Price Undertaking Agreement in China for Rémy Cointreau
Price Undertaking Agreement in China for Rémy Cointreau

Business Wire

time2 hours ago

  • Business Wire

Price Undertaking Agreement in China for Rémy Cointreau

PARIS--(BUSINESS WIRE)--Regulatory News: As part of the anti-dumping procedure initiated on January 5, 2024, by the Ministry of Commerce of the People's Republic of China (MOFCOM), Rémy Cointreau (Paris:RCO) announces the conclusion of an agreement between the Chinese authorities and certain cognac producers regarding 'Price Undertaking agreement' applicable to imports of grape-based spirits in containers of less than 200 liters originating from the European Union. Under this agreement, certain cognac stakeholders affected by the procedure commit, each according to their own terms, to comply with a minimum import price in China. In return, the 'definitive' anti-dumping duties that were to be imposed on European exports will not be applied (for reference, the official 'provisional' rate was 38.1% for Rémy Cointreau's cognac division since October 11, 2024, in the form of a guarantee-backed deposit, and was reduced to 34.3% in its final version). This agreement in no way constitutes an acknowledgment of dumping practices. While the commercial terms of this agreement are less favorable than those that were in effect prior to the initiation of the investigation, they nonetheless represent a significantly more favorable outcome, or at the very least, a substantially less punitive alternative, compared to the imposition of definitive anti-dumping duties. At this stage, Rémy Cointreau is still awaiting further details regarding the practical arrangements for implementing this agreement, in order to be able to assess the impacts accurately. Thanks to this agreement, these impacts are expected to be far less restrictive than those initially anticipated at the time of the annual results publication on June 4, 2025, and will enable the strengthening of some investments in China. As a result, Rémy Cointreau will update its annual guidance when publishing first-quarter results on July 25. About Rémy Cointreau All around the world, there are clients seeking exceptional experiences; clients for whom a wide range of terroirs means a variety of flavors. Their exacting standards are proportional to our expertise – the finely-honed skills that we pass down from generation to generation. The time these clients devote to drinking our products is a tribute to all those who have worked to develop them. It is for these men and women that Rémy Cointreau, a family-owned French Group, protects its terroirs, cultivates exceptional multi-centenary spirits and undertakes to preserve their eternal modernity. The Group's portfolio includes 14 singular brands, such as the Rémy Martin and LOUIS XIII cognacs, and Cointreau liqueur. Rémy Cointreau has a single ambition: becoming the world leader in exceptional spirits. To this end, it relies on the commitment and creativity of its 1,856 employees and on its distribution subsidiaries established in the Group's strategic markets. Rémy Cointreau is listed on Euronext Paris.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store